{
  "questions": [
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/39555889"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39555889",
          "text": "RankMHC: Learning to Rank Class-I Peptide-MHC Structural Models.. The binding of peptides to class-I Major Histocompability Complex (MHC) receptors and their subsequent recognition downstream by T-cell receptors are crucial processes for most mult...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.26385921239852905,
          "rerank_position": 1
        }
      ],
      "id": "67d74cde18b1e36f2e00003c",
      "type": "summary",
      "body": "Describe RankMHC"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29968252",
        "http://www.ncbi.nlm.nih.gov/pubmed/28825047",
        "http://www.ncbi.nlm.nih.gov/pubmed/28741479",
        "http://www.ncbi.nlm.nih.gov/pubmed/34909395",
        "http://www.ncbi.nlm.nih.gov/pubmed/37681286",
        "http://www.ncbi.nlm.nih.gov/pubmed/30796810",
        "http://www.ncbi.nlm.nih.gov/pubmed/32463385",
        "http://www.ncbi.nlm.nih.gov/pubmed/34638407",
        "http://www.ncbi.nlm.nih.gov/pubmed/26457759",
        "http://www.ncbi.nlm.nih.gov/pubmed/33571895"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29968252",
          "text": "Consensus molecular subtype classification of colorectal adenomas.. Consensus molecular subtyping is an RNA expression-based classification system for colorectal cancer (CRC). Genomic alterations accumulate during CRC pathogenesis, including the p...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6614941358566284,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28825047",
          "text": "Consensus Molecular Subtypes of Colorectal Cancer and their Clinical Implications.. The colorectal cancer (CRC) Subtyping Consortium has unified six independent molecular classification systems, based on gene expression data, into a single consens...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6601976752281189,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28741479",
          "text": "Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation.. Cancer is a heterogeneous disease and many cancer types do not represent a single entity, but are composed of biologically and clinically diverse subtypes. The su...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6544574499130249,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34909395",
          "text": "Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach.. The identification of several genetic mutations in colorectal cancer (CRC) has allowed a better comprehension of the prognosis and response to diffe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6530706286430359,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37681286",
          "text": "Consensus molecular subtype transition during progression of colorectal cancer.. The consensus molecular subtype (CMS) classification divides colorectal cancer (CRC) into four distinct subtypes based on RNA expression profiles. The biological diff...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6485147476196289,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30796810",
          "text": "Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials.. The Colorectal Cancer Subtyping Consortium identified four gene expression consensus molecular subtypes, CMS1 (immune), CMS2 (canonical), CMS3 (m...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6326359510421753,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32463385",
          "text": "Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision.. Background Colorectal cancer (CRC) is one of the most common types of cancer in the world. Metastatic disease is still incurable in most of these...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6313056945800781,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34638407",
          "text": "Implications of Intratumor Heterogeneity on Consensus Molecular Subtype (CMS) in Colorectal Cancer.. The implications of intratumor heterogeneity on the four consensus molecular subtypes (CMS) of colorectal cancer (CRC) are not well known. Here, w...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6288520693778992,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26457759",
          "text": "The consensus molecular subtypes of colorectal cancer.. Colorectal cancer (CRC) is a frequently lethal disease with heterogeneous outcomes and drug responses. To resolve inconsistencies among the reported gene expression-based CRC classifications ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.623961329460144,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33571895",
          "text": "Consensus molecular subtyping of colorectal cancers is influenced by goblet cell content.. A critical obstacle in the field of colorectal cancer (CRC) is the establishment of precise tumor subtypes to facilitate the development of targeted therape...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6142244338989258,
          "rerank_position": 10
        }
      ],
      "id": "65f7741fc4010b4d78000027",
      "type": "factoid",
      "body": "What proportion of colorectal cancer cases are not assignable to any of the consensus molecular subtype (CMS) groups?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23869678",
        "http://www.ncbi.nlm.nih.gov/pubmed/31350821",
        "http://www.ncbi.nlm.nih.gov/pubmed/17017939",
        "http://www.ncbi.nlm.nih.gov/pubmed/12166544",
        "http://www.ncbi.nlm.nih.gov/pubmed/17694282",
        "http://www.ncbi.nlm.nih.gov/pubmed/26122487",
        "http://www.ncbi.nlm.nih.gov/pubmed/17305582",
        "http://www.ncbi.nlm.nih.gov/pubmed/37484720",
        "http://www.ncbi.nlm.nih.gov/pubmed/20402554",
        "http://www.ncbi.nlm.nih.gov/pubmed/20101899"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23869678",
          "text": "PDE5 inhibitors: considerations for preference and long-term adherence.. INTRODUCTION: Erectile dysfunction (ED) is a highly prevalent condition affecting nearly one in five men worldwide. The advent of phosphodiesterase type 5 inhibitors (PDE5i) ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5621333718299866,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31350821",
          "text": "The first-generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue.. BACKGROUND: Erectile dysfunction (ED) is a relatively frequent disease that negatively impacts the overall quality of life, well-being, and relationships. Althou...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.533631443977356,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17017939",
          "text": "Phosphodiesterase 5 inhibitors--drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles.. The discovery that inhibition of phosphodiesterase-5 (PDE5) reduces the degradation of cGMP, allowing erectile function t...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.522060751914978,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12166544",
          "text": "Pharmacology of phosphodiesterase-5 inhibitors.. The clinical properties (efficacy and safety profile) of a medicine are related not only to its mode of action, but also to its selectivity for its target (usually a receptor or enzyme) and are also...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.515960693359375,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17694282",
          "text": "[Novel indications for phosphodiesterase type 5 inhibitors].. Phosphodiesterase type 5 (PDE5) induces the breakdown of cyclic guanosine monophosphate (cGMP) in smooth muscle cells. Hence, PDE5 inhibitors promote vasodilative effects by enhancing i...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5103053450584412,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26122487",
          "text": "Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications.. PDE5 inhibitors (PDE5i) are widely known as treatment for erectile dysfunction (ED). This favorable action has emerged as a \"side effect\" from pioneering studies when...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5066299438476562,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17305582",
          "text": "Design of second generation phosphodiesterase 5 inhibitors.. The clinical significance of phosphodiesterase 5 (PDE5) inhibition is increasingly understood following the pioneering work with sildenafil, and the continuing development programmes for...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4986915588378906,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37484720",
          "text": "Phosphodiesterase-5 Inhibitors as Therapeutics for Cardiovascular Diseases: A Brief Review.. BACKGROUND: Three selective and most used inhibitors of PDE-5-sildenafil, vardenafil and tadalafil- have been successfully used for the treatment of erect...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4952046275138855,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20402554",
          "text": "Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction.. IMPORTANCE TO THE FIELD: Since sildenafil was introduced 10 years ago, highly selective phosphodiesterase type 5 inhibitors (PDE5i) have changed the medical man...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4924980401992798,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20101899",
          "text": "[Clinical use of phosphodiesterase-5 inhibitors in cardiopulmonary diseases: from experimental evidence to clinical application].. Phosphodiesterases are a class of proteins that primarily modulate intracellular levels of cyclic nucleotides such a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4878532886505127,
          "rerank_position": 10
        }
      ],
      "id": "67cc973e81b1027333000011",
      "type": "list",
      "body": "Please list the short half life Phosphodiesterase 5 inhibitors."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23066308",
        "http://www.ncbi.nlm.nih.gov/pubmed/16898611",
        "http://www.ncbi.nlm.nih.gov/pubmed/26167065",
        "http://www.ncbi.nlm.nih.gov/pubmed/17267314",
        "http://www.ncbi.nlm.nih.gov/pubmed/24627583",
        "http://www.ncbi.nlm.nih.gov/pubmed/19300123",
        "http://www.ncbi.nlm.nih.gov/pubmed/31594651",
        "http://www.ncbi.nlm.nih.gov/pubmed/34304785",
        "http://www.ncbi.nlm.nih.gov/pubmed/15862931",
        "http://www.ncbi.nlm.nih.gov/pubmed/16718806"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23066308",
          "text": "Irritable bowel syndrome: diagnosis and pathogenesis.. Irritable bowel syndrome (IBS) is a common gastrointestinal (GI) disorder that considerably reduces the quality of life. It further represents an economic burden on society due to the high con...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.9189028739929199,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16898611",
          "text": "[Pathophysiology of irritable bowel syndrome].. Irritable bowel syndrome (IBS) is considered a biopsychosocial disorder resulting from a combination of 3 interacting mechanisms: psychosocial factors, altered motility and transit, which may reflect...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.917739987373352,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26167065",
          "text": "Recent developments in the pathophysiology of irritable bowel syndrome.. Irritable bowel syndrome (IBS) is a common gastrointestinal disorder, the pathophysiology of which is not completely known, although it has been shown that genetic/social lea...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.90434730052948,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17267314",
          "text": "New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.. The pathogenesis and pathophysiology of irritable bowel syndrome is complex and still incompletely known. Potential pathogenetic factors include genes, infectious...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.9003749489784241,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24627583",
          "text": "Irritable bowel syndrome: emerging paradigm in pathophysiology.. Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders, characterized by abdominal pain, bloating, and changes in bowel habits. These symptoms cannot be ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8973579406738281,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19300123",
          "text": "Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut?. Recent in-depth studies of irritable bowel syndrome (IBS) that assessed multiple physiological endpoints in large patient cohorts confirm evidence o...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8925435543060303,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31594651",
          "text": "Pathophysiology of the irritable bowel syndrome - Reflections of today.. Irritable bowel syndrome (IBS) is a chronic gastrointestinal symptom complex defined by abdominal pain and disturbed bowel habits over 3 months within a period of 6 months, i...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8901309370994568,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34304785",
          "text": "Latest Insights on the Pathogenesis of Irritable Bowel Syndrome.. The pathogenesis of irritable bowel syndrome is multifactorial and complex. Our understanding of its pathophysiology has evolved, but remains incompletely understood. Symptoms resul...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8884298205375671,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15862931",
          "text": "Disturbances of motility and visceral hypersensitivity in irritable bowel syndrome: biological markers or epiphenomenon.. Motility and visceral hypersentitivity are regarded as the primary mechanisms of symptom development in irritable bowel syndr...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8868702054023743,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16718806",
          "text": "Functional findings in irritable bowel syndrome.. The pathophysiology of IBS is complex and still incompletely known. Both central and peripheral factors, including psychosocial factors, abnormal GI motility and secretion, and visceral hypersensit...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.886290431022644,
          "rerank_position": 10
        }
      ],
      "id": "67d722e818b1e36f2e000036",
      "type": "summary",
      "body": "Pathophysiology of irritable bowel syndrome (IBS)."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23649974",
        "http://www.ncbi.nlm.nih.gov/pubmed/25344858",
        "http://www.ncbi.nlm.nih.gov/pubmed/21933973",
        "http://www.ncbi.nlm.nih.gov/pubmed/27048336",
        "http://www.ncbi.nlm.nih.gov/pubmed/20809868",
        "http://www.ncbi.nlm.nih.gov/pubmed/28072762",
        "http://www.ncbi.nlm.nih.gov/pubmed/22187964",
        "http://www.ncbi.nlm.nih.gov/pubmed/26951083",
        "http://www.ncbi.nlm.nih.gov/pubmed/25139999",
        "http://www.ncbi.nlm.nih.gov/pubmed/39924521"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649974",
          "text": "The receptor tyrosine kinase Axl in cancer: biological functions and therapeutic implications.. The receptor tyrosine kinase Axl has been implicated in the malignancy of different types of cancer. Emerging evidence of Axl upregulation in numerous ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7901603579521179,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25344858",
          "text": "Axl as a mediator of cellular growth and survival.. The control of cellular growth and proliferation is key to the maintenance of homeostasis. Survival, proliferation, and arrest are regulated, in part, by Growth Arrest Specific 6 (Gas6) through b...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7750684022903442,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21933973",
          "text": "Targeting Axl and Mer kinases in cancer.. Receptor tyrosine kinases (RTK) are cell-surface transmembrane receptors that contain regulated kinase activity within their cytoplasmic domain and play an important role in signal transduction in both nor...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7730036973953247,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27048336",
          "text": "Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells.. Aberrant expression and activation of receptor tyrosine kinases (RTK) is a frequent feature of tumor cells that may underlie tumor aggressiveness. Among RTK, Axl, a membe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7715859413146973,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20809868",
          "text": "Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.. IMPORTANCE OF THE FIELD: Axl and/or Mer expression correlates with poor prognosis in several cancers. Until recently, the role of these receptor tyr...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7553104162216187,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28072762",
          "text": "Giving AXL the axe: targeting AXL in human malignancy.. The receptor tyrosine kinase AXL, activated by a complex interaction between its ligand growth arrest-specific protein 6 and phosphatidylserine, regulates various vital cellular processes, in...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7513217926025391,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22187964",
          "text": "Axl-dependent signalling: a clinical update.. Axl is a receptor tyrosine kinase that was originally cloned from cancer cells. Axl belongs to the TAM (Tyro3, Axl and Mertk) family of receptor tyrosine kinases. Gas6 (growth-arrest-specific protein 6...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7464035749435425,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951083",
          "text": "Gene of the month: Axl.. The interaction between Axl receptor tyrosine kinase and its main ligand Gas6 has been implicated in the progression of a wide number of malignancies. More recently, overexpression of Axl has emerged as a key molecular det...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7409855127334595,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25139999",
          "text": "Axl kinase as a key target for oncology: focus on small molecule inhibitors.. Receptor tyrosine kinases (RTK) are transmembrane receptors that regulate signal transduction in cells. As a member of the TAM (Tyro-3, Axl, Mer) RTK subfamily, Axl regu...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7264127135276794,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39924521",
          "text": "AXL signaling in cancer: from molecular insights to targeted therapies.. AXL, a member of the TAM receptor family, has emerged as a potential target for advanced-stage human malignancies. It is frequently overexpressed in different cancers and pla...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7240316271781921,
          "rerank_position": 10
        }
      ],
      "id": "67da17c918b1e36f2e000055",
      "type": "summary",
      "body": "What is the role of the receptor tyrosine kinase AXL in malignancy?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/9014949",
        "http://www.ncbi.nlm.nih.gov/pubmed/36571207",
        "http://www.ncbi.nlm.nih.gov/pubmed/22084278",
        "http://www.ncbi.nlm.nih.gov/pubmed/863687",
        "http://www.ncbi.nlm.nih.gov/pubmed/23836708",
        "http://www.ncbi.nlm.nih.gov/pubmed/7207506",
        "http://www.ncbi.nlm.nih.gov/pubmed/20823007",
        "http://www.ncbi.nlm.nih.gov/pubmed/6244625",
        "http://www.ncbi.nlm.nih.gov/pubmed/30553654",
        "http://www.ncbi.nlm.nih.gov/pubmed/36596294"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9014949",
          "text": "Clinical implications of maximal respiratory pressure determinations for individuals with Duchenne muscular dystrophy.. OBJECTIVE: To analyze the relationship between disease progression, pulmonary volumes, respiratory muscle strength (maximum ins...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7426386475563049,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36571207",
          "text": "Spirometry correlates with physical activity in patients with Duchenne muscular dystrophy.. BACKGROUND: Duchenne muscular dystrophy (DMD) is associated with progressive muscle weakness and respiratory decline. To date, studies have focused on resp...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7143999338150024,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22084278",
          "text": "SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy: predicting the severity of Duchenne muscular dystrophy: implications for treatment.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 166,
          "rerank_score": 0.7100618481636047,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/863687",
          "text": "Respiratory function and pulmonary infection in Duchenne muscular dystrophy.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 76,
          "rerank_score": 0.7089378833770752,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23836708",
          "text": "Respiratory muscle decline in Duchenne muscular dystrophy.. OBJECTIVES: Duchenne muscular dystrophy (DMD) causes progressive respiratory muscle weakness. The aim of the study was to analyze the trend of a large number of respiratory parameters to ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7049497365951538,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7207506",
          "text": "Respiratory function in the muscular dystrophies.. The purpose of this investigation was to compare the respiratory function of patients with different clinical types of muscular dystrophy (MD). A total of 190 patients representing facioscapulohum...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6990960836410522,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20823007",
          "text": "Clinical implications of MRI to assess cardiac and pulmonary function in patients with duchenne muscular dystrophy.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 115,
          "rerank_score": 0.6908808946609497,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6244625",
          "text": "[The respiratory function in muscular dystrophies (author's transl)].. The principal cause of death in Duchenne muscular dystrophy (DMD) results from a respiratory involvement, classically defined as a restrictive syndrome. The respiratory functio...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6876341104507446,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30553654",
          "text": "Duchenne Muscular Dystrophy longitudinal pulmonary assessment and management.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 77,
          "rerank_score": 0.686369001865387,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36596294",
          "text": "Pulmonary function tests for evaluating the severity of Duchenne muscular dystrophy disease.. AIM: In Duchenne muscular dystrophy (DMD), lung disease contributes significantly to morbidity and mortality. This study aimed to assess the usefulness o...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6859810948371887,
          "rerank_position": 10
        }
      ],
      "id": "66301d1d187cba990d000026",
      "type": "yesno",
      "body": "Are respiratory measurements correlated with disease severity in Duchenne Muscular Dystrophy?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/37650884",
        "http://www.ncbi.nlm.nih.gov/pubmed/28007905",
        "http://www.ncbi.nlm.nih.gov/pubmed/39030458",
        "http://www.ncbi.nlm.nih.gov/pubmed/38131667",
        "http://www.ncbi.nlm.nih.gov/pubmed/35986737",
        "http://www.ncbi.nlm.nih.gov/pubmed/35512140",
        "http://www.ncbi.nlm.nih.gov/pubmed/10563640",
        "http://www.ncbi.nlm.nih.gov/pubmed/15325839",
        "http://www.ncbi.nlm.nih.gov/pubmed/24336069",
        "http://www.ncbi.nlm.nih.gov/pubmed/38549004"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37650884",
          "text": "Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 135,
          "rerank_score": 0.6354317665100098,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28007905",
          "text": "Novel UCHL1 mutations reveal new insights into ubiquitin processing.. Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 has been implicated in early-onset progressive neurodegeneration (MIM no. 615491), so far only in one family...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5062264800071716,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39030458",
          "text": "Phenotypic variability related to dominant UCHL1 mutations: about three families with optic atrophy and ataxia.. INTRODUCTION: Ubiquitin C-terminal hydrolase L1 (UCHL1) has been associated with a severe, complex autosomal recessive spastic paraple...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4904179871082306,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38131667",
          "text": "Digenic FLNA and UCHL1 variants resulting in a complex phenotype.. AIM: X-linked variants in Filamin A (FLNA) are associated with the Ehlers-Danlos-syndrome-variant form of periventricular heterotopia, and autosomal dominant variants in ubiquitin ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.46873027086257935,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35986737",
          "text": "Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy.. PURPOSE: Biallelic variants in UCHL1 have been associated with a progressive early-onset neurodegenerative dis...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4362602233886719,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35512140",
          "text": "The requirement of ubiquitin C-terminal hydrolase L1 in mouse ovarian development and fertility†.. Ubiquitin C-terminal hydrolase L1 (UCHL1) is a de-ubiquitinating enzyme enriched in neuronal and gonadal tissues known to regulate the cellular stor...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3780887722969055,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10563640",
          "text": "Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease.. We investigated the association of PD with a recently reported I93M mutation of the ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene, and with a n...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3011026978492737,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15325839",
          "text": "Pathogenetic mechanisms of parkin in Parkinson's disease.. CONTEXT: The cause and pathogenesis of Parkinson's disease remain unknown; mitochondrial dysfunction, oxidative damage, environmental factors, and genetic predisposition might all be invol...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.2767641544342041,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24336069",
          "text": "Differentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biology.. Autosomal dominant osteopetrosis type II (ADO II) is a rare, heritable bone disorder characterized by a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.22343432903289795,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38549004",
          "text": "Variants in mitochondrial disease genes are common causes of inherited peripheral neuropathies.. BACKGROUND: Peripheral neuropathies in mitochondrial disease are caused by mutations in nuclear genes encoding mitochondrial proteins, or in the mitoc...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.2221362292766571,
          "rerank_position": 10
        }
      ],
      "id": "67d3518718b1e36f2e000008",
      "type": "factoid",
      "body": "Which disease is caused by heterozygous UCHL1 loss-of-function variants?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/31687149",
        "http://www.ncbi.nlm.nih.gov/pubmed/28927777",
        "http://www.ncbi.nlm.nih.gov/pubmed/25129331",
        "http://www.ncbi.nlm.nih.gov/pubmed/23726258",
        "http://www.ncbi.nlm.nih.gov/pubmed/23980038",
        "http://www.ncbi.nlm.nih.gov/pubmed/24985058",
        "http://www.ncbi.nlm.nih.gov/pubmed/28224365",
        "http://www.ncbi.nlm.nih.gov/pubmed/26298902",
        "http://www.ncbi.nlm.nih.gov/pubmed/34572817",
        "http://www.ncbi.nlm.nih.gov/pubmed/33189037"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31687149",
          "text": "Use of perioperative chemotherapy in colorectal cancer metastatic to the liver.. A curative-intent approach may improve survival in carefully selected patients with oligometastatic colorectal cancer. Aggressive treatments are most frequently admin...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7555369138717651,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28927777",
          "text": "The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resection.. In patients with metastatic colorectal cancer (mCRC) predominantly confined to the liver, whether a patient undergoes potentially curativ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7234452962875366,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25129331",
          "text": "Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment.. Colorectal cancer is a common malignancy and often presents with synchronous or metachronous distant spread. For patients with hepatic metastases, resection i...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7221007943153381,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23726258",
          "text": "Perioperative chemotherapy for resectable colorectal liver metastases: where now?. Following the publication of the EORTC trial (40983), perioperative chemotherapy has become the standard of care for all patients with resectable colorectal cancer ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7218238711357117,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23980038",
          "text": "[Consideration of therapy for colorectal cancer with synchronous unresectable liver metastasis].. A variety of managements, including systemic and local chemotherapy, radiofrequency ablation and others, are used after multidisciplinary team discus...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7202568650245667,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24985058",
          "text": "Potentially resectable metastatic colorectal cancer: an individualized approach to conversion therapy.. Colorectal cancer is one of the most common cancers worldwide. In recent years, the survival of patients with metastatic disease has improved d...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7134332060813904,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28224365",
          "text": "Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis.. PURPOSE AND DESIGN: Optimal surgical strategy for resectable synchronous colorectal cancer with liver metastasis (SCRLM) remains a therapeutic dilemma. Multiple re...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7054026126861572,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26298902",
          "text": "[Management of metastatic colorectal cancer].. Prognosis of metastatic colorectal cancer has dramatically improved during these two last decades, through a better understanding of therapeutic goals and the development of news drugs such as biologi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7035449743270874,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34572817",
          "text": "Perioperative Systemic Chemotherapy for Colorectal Liver Metastasis: Recent Updates.. The liver is the most common site of metastases for colorectal cancer. Complete resection in some patients with resectable liver metastases (LM) can lead to long...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7030738592147827,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33189037",
          "text": "Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review.. BACKGROUND: There is no consensus on the optimal systemic conversion therapy in patients with unresectable colorectal c...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6990751624107361,
          "rerank_position": 10
        }
      ],
      "id": "662154f0b9f8b89d7e000009",
      "type": "factoid",
      "body": "What is the most appropriate systemic treatment for conversion therapy in colorectal cancer with potentially resectable liver metastasis?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25702256",
        "http://www.ncbi.nlm.nih.gov/pubmed/24581182",
        "http://www.ncbi.nlm.nih.gov/pubmed/23933169",
        "http://www.ncbi.nlm.nih.gov/pubmed/36113764",
        "http://www.ncbi.nlm.nih.gov/pubmed/10420212",
        "http://www.ncbi.nlm.nih.gov/pubmed/36938233",
        "http://www.ncbi.nlm.nih.gov/pubmed/10150870",
        "http://www.ncbi.nlm.nih.gov/pubmed/20711706",
        "http://www.ncbi.nlm.nih.gov/pubmed/9577117",
        "http://www.ncbi.nlm.nih.gov/pubmed/32197861"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25702256",
          "text": "[The age-related macular degeneration as a vascular disease/part of systemic vasculopathy: contributions to its pathogenesis].. The wall of blood vessels including those in choroids may be harmed by several repeated and/or prolonged mechanical, ph...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6395522952079773,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24581182",
          "text": "Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment.. Age-related macular degeneration (AMD) is a common vision-threatening condition affecting the elderly. AMD shares common ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6298641562461853,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23933169",
          "text": "Aging is not a disease: distinguishing age-related macular degeneration from aging.. Age-related macular degeneration (AMD) is a disease of the outer retina, characterized most significantly by atrophy of photoreceptors and retinal pigment epithel...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6258425712585449,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36113764",
          "text": "Interplay between aging and other factors of the pathogenesis of age-related macular degeneration.. Age-related macular degeneration (AMD) is a complex eye disease with the retina as the target tissue and aging as per definition the most serious r...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6244450211524963,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10420212",
          "text": "Do age-related macular degeneration and cardiovascular disease share common antecedents?. Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss and blindness in elderly Americans. The etiology of this condition re...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6184954047203064,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36938233",
          "text": "Age-Related Macular Degeneration and Its Association With Neurodegenerative Disorders.. Age-related macular degeneration (AMD) is a highly prevalent macular condition that primarily affects the older population. It is the primary cause of blindnes...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6127947568893433,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10150870",
          "text": "Prevalence of age-related macular degeneration.. Early and late age-related macular degeneration (AMD) have a high prevalence in elderly patients but may be differentiated by medical or environmental factors, eg, hypertension, geographic area, or ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6071517467498779,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20711706",
          "text": "Genetic control of complement activation in humans and age related macular degeneration.. The major focus of our research is to understand how age-related macular degeneration (AMD) develops. It is known that genetic variation can explain much of ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6033216714859009,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9577117",
          "text": "[Age related macular degeneration as a cause of blindness].. PURPOSE: To present our studies concerning the causes of blindness in age-related macular degeneration, including the relationship with risk factors for this disease. MATERIAL AND METHOD...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6011648178100586,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32197861",
          "text": "New frontiers and clinical implications in the pathophysiology of age-related macular degeneration.. Age-related macular degeneration (AMD) involves progressive degeneration of the central retina, termed the macula, which provides high-acuity visi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5914196372032166,
          "rerank_position": 10
        }
      ],
      "id": "67c847f581b1027333000003",
      "type": "yesno",
      "body": "Is age an underlying factor in the eye disease AMD?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/27028561",
        "http://www.ncbi.nlm.nih.gov/pubmed/27290831",
        "http://www.ncbi.nlm.nih.gov/pubmed/26965962",
        "http://www.ncbi.nlm.nih.gov/pubmed/28340908",
        "http://www.ncbi.nlm.nih.gov/pubmed/29267910",
        "http://www.ncbi.nlm.nih.gov/pubmed/28656018",
        "http://www.ncbi.nlm.nih.gov/pubmed/27295893",
        "http://www.ncbi.nlm.nih.gov/pubmed/29267909",
        "http://www.ncbi.nlm.nih.gov/pubmed/35918360",
        "http://www.ncbi.nlm.nih.gov/pubmed/27156484"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27028561",
          "text": "Zika Virus.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 11,
          "rerank_score": 0.8752039670944214,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27290831",
          "text": "[Zika virus].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 13,
          "rerank_score": 0.8593333959579468,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26965962",
          "text": "Zika virus infection-the next wave after dengue?. Zika virus was initially discovered in east Africa about 70 years ago and remained a neglected arboviral disease in Africa and Southeast Asia. The virus first came into the limelight in 2007 when i...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7446897625923157,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28340908",
          "text": "Preparing the United States for Zika Virus: Pre-emptive Vector Control and Personal Protection.. Discovered in 1947 in a monkey in the Zika forest of Uganda, Zika virus was dismissed as a cause of a mild illness that was confined to Africa and Sou...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7416526079177856,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29267910",
          "text": "Zika Virus Mosquito Vectors: Competence, Biology, and Vector Control.. Zika virus (ZIKV) (Flaviviridae, Flavivirus) has become one of the most medically important mosquito-borne viruses because of its ability to cause microcephaly in utero and Gui...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7409052848815918,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28656018",
          "text": "Zika Virus and Sexual Transmission: A New Route of Transmission for Mosquito-borne Flaviviruses .. Beginning in 2015, concern over a new global epidemic has spread in the media, governmental agencies, legislative bodies and the public at large. Th...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7294721007347107,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27295893",
          "text": "[Zika Virus and Zika Viral Disease].. Since Zika virus (ZIKV) has firstly been isolated in 1947, Uganda, outbreaks of Zika fever have been reported in many areas such as in Africa, Southeast Asia and America. Imported cases in China also have been...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7179684638977051,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29267909",
          "text": "Modes of Transmission of Zika Virus.. For >60 years, Zika virus (ZIKV) has been recognized as an arthropod-borne virus with Aedes species mosquitoes as the primary vector. However in the past 10 years, multiple alternative routes of ZIKV transmiss...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7100287675857544,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35918360",
          "text": "Zika vector competence data reveals risks of outbreaks: the contribution of the European ZIKAlliance project.. First identified in 1947, Zika virus took roughly 70 years to cause a pandemic unusually associated with virus-induced brain damage in n...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7096801996231079,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27156484",
          "text": "[Zika virus infection or the future of infectious diseases].. Zika virus belongs to the Flaviridae, an extended phylogenetic family containing dengue or yellow fever, viruses whose shared main vector are Aedes aegypti mosquitoes. The virus origina...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.708262026309967,
          "rerank_position": 10
        }
      ],
      "id": "67d7fe2618b1e36f2e000044",
      "type": "factoid",
      "body": "Vector of zika virus."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/30662831",
        "http://www.ncbi.nlm.nih.gov/pubmed/18497759",
        "http://www.ncbi.nlm.nih.gov/pubmed/20145155",
        "http://www.ncbi.nlm.nih.gov/pubmed/34894431",
        "http://www.ncbi.nlm.nih.gov/pubmed/34771555",
        "http://www.ncbi.nlm.nih.gov/pubmed/22228704",
        "http://www.ncbi.nlm.nih.gov/pubmed/39893170",
        "http://www.ncbi.nlm.nih.gov/pubmed/28062830",
        "http://www.ncbi.nlm.nih.gov/pubmed/38766170",
        "http://www.ncbi.nlm.nih.gov/pubmed/38826227"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30662831",
          "text": "Rogue one: another faction of the Wnt empire implicated in assisting GBM progression.. It remains incumbent on researchers to conceive novel treatments for the most common primary malignancy of the brain in adults, glioblastoma multiforme (GBM), a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6681536436080933,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18497759",
          "text": "Mesenchymal differentiation of glioblastoma stem cells.. Glioblastoma multiforme is a severe form of cancer most likely arising from the transformation of stem or progenitor cells resident in the brain. Although the tumorigenic population in gliob...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6432060599327087,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20145155",
          "text": "Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin.. Glioblastoma multiforme (GBM) is paradigmatic for the investigation of cancer stem cells (CSC) in solid tumors. Growing e...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.638648271560669,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34894431",
          "text": "Transcription factors in glioblastoma - Molecular pathogenesis and clinical implications.. Glioblastoma, also known as glioblastoma multiforme (GBM), is one of the most lethal human cancers, however, the molecular mechanisms driving GBM remain lar...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6290135383605957,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34771555",
          "text": "SLUG and Truncated TAL1 Reduce Glioblastoma Stem Cell Growth Downstream of Notch1 and Define Distinct Vascular Subpopulations in Glioblastoma Multiforme.. Glioblastomas (GBM) are high-grade brain tumors, containing cells with distinct phenotypes a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6279489398002625,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22228704",
          "text": "REST regulates oncogenic properties of glioblastoma stem cells.. Glioblastoma multiforme (GBM) tumors are the most common malignant primary brain tumors in adults. Although many GBM tumors are believed to be caused by self-renewing, glioblastoma-d...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6174914836883545,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39893170",
          "text": "Network analyses of brain tumor multiomic data reveal pharmacological opportunities to alter cell state transitions.. Glioblastoma Multiforme (GBM) remains a particularly difficult cancer to treat, and survival outcomes remain poor. In addition to...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6161240935325623,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28062830",
          "text": "Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models.. BACKGROUND: Molecular profile of glioblastoma multiforme (GBM) revealed 4 subtypes, 2 of which, proneural and mesenchymal, have been predominantly observ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6132711172103882,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38766170",
          "text": "Network Analyses of Brain Tumor Patients' Multiomic Data Reveals Pharmacological Opportunities to Alter Cell State Transitions.. Glioblastoma Multiforme (GBM) remains a particularly difficult cancer to treat, and survival outcomes remain poor. In ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6131970286369324,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38826227",
          "text": "Network Analyses of Brain Tumor Patients' Multiomic Data Reveals Pharmacological Opportunities to Alter Cell State Transitions.. Glioblastoma Multiforme (GBM) remains a particularly difficult cancer to treat, and survival outcomes remain poor. In ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6131970286369324,
          "rerank_position": 10
        }
      ],
      "id": "67d7503018b1e36f2e00003e",
      "type": "list",
      "body": "What are the main transcription factors driving the mesenchymal-like (MES-like) state of glioblastoma multiforme?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/31824583",
        "http://www.ncbi.nlm.nih.gov/pubmed/38978724",
        "http://www.ncbi.nlm.nih.gov/pubmed/38685975",
        "http://www.ncbi.nlm.nih.gov/pubmed/37450567",
        "http://www.ncbi.nlm.nih.gov/pubmed/37917284",
        "http://www.ncbi.nlm.nih.gov/pubmed/32939785",
        "http://www.ncbi.nlm.nih.gov/pubmed/37621409",
        "http://www.ncbi.nlm.nih.gov/pubmed/36034314",
        "http://www.ncbi.nlm.nih.gov/pubmed/32851396",
        "http://www.ncbi.nlm.nih.gov/pubmed/14682249"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31824583",
          "text": "Investigation of the RFC1 Repeat Expansion in a Canadian and a Brazilian Ataxia Cohort: Identification of Novel Conformations.. A biallelic pentanucleotide expansion in the RFC1 gene has been reported to be a common cause of late-onset ataxia. In ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5679148435592651,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38978724",
          "text": "Pathologic RFC1 repeat expansions do not contribute to the development of inflammatory neuropathies.. Biallelic expansions of the AAGGG repeat in the replication factor C subunit 1 (RFC1) have recently been described to be responsible for cerebell...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5640353560447693,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38685975",
          "text": "RFC1 Repeat Distribution in the Cypriot Population: Study of a Large Cohort of Patients With Undiagnosed Ataxia and Non-Disease Controls.. BACKGROUND AND OBJECTIVES: The intronic biallelic AAGGG expansion in the replication factor C subunit 1 (RFC...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5291035175323486,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37450567",
          "text": "Normal and pathogenic variation of RFC1 repeat expansions: implications for clinical diagnosis.. Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) is an autosomal recessive neurodegenerative disease, usually caused by bialle...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5289779305458069,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37917284",
          "text": "Investigation of RFC1 tandem nucleotide repeat locus in diverse neurodegenerative outcomes in an Indian cohort.. An intronic bi-allelic pentanucleotide repeat expansion mutation, (AAGGG)400-2000, at AAAAG repeat locus in RFC1 gene, is known as und...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4954349100589752,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32939785",
          "text": "Biallelic Intronic AAGGG Expansion of RFC1 is Related to Multiple System Atrophy.. OBJECTIVE: A recessive biallelic repeat expansion, (AAGGG)exp , in the RFC1 gene has been reported to be a frequent cause of late-onset ataxia. For cerebellar ataxi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.467629998922348,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37621409",
          "text": "RFC1 in an Australasian neurological disease cohort: extending the genetic heterogeneity and implications for diagnostics.. Cerebellar ataxia, neuropathy and vestibular areflexia syndrome is a progressive, generally late-onset, neurological disord...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.45025748014450073,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36034314",
          "text": "Genetic and clinical features of cerebellar ataxia with RFC1 biallelic repeat expansions in Japan.. The recessive intronic pentanucleotide repeat AAGGG expansion of replication factor complex subunit 1 (RFC1) is associated with cerebellar ataxia, ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.41148704290390015,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32851396",
          "text": "A Māori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele.. Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS) is a recently recognized neurodegenerative disease with onset ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3424825370311737,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14682249",
          "text": "[Sequence variation of D12S391 and D11S554 loci in Guangzhou han population].. To study the core sequence of the hypervariable short tandom repeats, we sequenced the alleles of D12S391 and D11S554 loci which show high mutation rate in Guangzhou Ha...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.23676131665706635,
          "rerank_position": 10
        }
      ],
      "id": "67d34fb318b1e36f2e000007",
      "type": "factoid",
      "body": "Which role does AAAGG have in RFC1 repeat expansions?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/34909395",
        "http://www.ncbi.nlm.nih.gov/pubmed/34077519",
        "http://www.ncbi.nlm.nih.gov/pubmed/33005848",
        "http://www.ncbi.nlm.nih.gov/pubmed/28505475",
        "http://www.ncbi.nlm.nih.gov/pubmed/28741479",
        "http://www.ncbi.nlm.nih.gov/pubmed/37345083",
        "http://www.ncbi.nlm.nih.gov/pubmed/32463385",
        "http://www.ncbi.nlm.nih.gov/pubmed/37970108",
        "http://www.ncbi.nlm.nih.gov/pubmed/31042420",
        "http://www.ncbi.nlm.nih.gov/pubmed/29968252"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34909395",
          "text": "Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach.. The identification of several genetic mutations in colorectal cancer (CRC) has allowed a better comprehension of the prognosis and response to diffe...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7681597471237183,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34077519",
          "text": "Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis.. BACKGROUND: The consensus molecular subtypes (CMSs) of colorectal cancer (CRC) capture tumor heterogeneity at the gene-expression level. C...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7618083953857422,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33005848",
          "text": "Investigation of colorectal cancer in accordance with consensus molecular subtype classification.. The classification of colorectal cancer (CRC) plays a pivotal role in predicting a patient's prognosis and determining treatment strategies. The con...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7545981407165527,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28505475",
          "text": "Colorectal cancer subtypes: Translation to routine clinical pathology.. Colorectal cancer (CRC) is the second most common cause of cancer death in Europe. Although outcomes have improved, it is clear that from a genomic standpoint CRC is not one d...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7396184206008911,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28741479",
          "text": "Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation.. Cancer is a heterogeneous disease and many cancer types do not represent a single entity, but are composed of biologically and clinically diverse subtypes. The su...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7274397611618042,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37345083",
          "text": "Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management.. Colorectal cancer (CRC) is the second cause of cancer-related deaths in both sexes globally and presents different clinical outcomes that are described by a r...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7267495393753052,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32463385",
          "text": "Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision.. Background Colorectal cancer (CRC) is one of the most common types of cancer in the world. Metastatic disease is still incurable in most of these...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.72062087059021,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37970108",
          "text": "Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study.. BACKGROUND: Colorectal cancer is a complex disease with high mortality rates. Over time, the treatment of metastatic co...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7198373079299927,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31042420",
          "text": "Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance).. PURPOSE: To determine the predictive and prognostic value of the consensus molecular subtypes (CMSs) of col...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7059160470962524,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29968252",
          "text": "Consensus molecular subtype classification of colorectal adenomas.. Consensus molecular subtyping is an RNA expression-based classification system for colorectal cancer (CRC). Genomic alterations accumulate during CRC pathogenesis, including the p...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7009726762771606,
          "rerank_position": 10
        }
      ],
      "id": "662fc277187cba990d000013",
      "type": "yesno",
      "body": "Does the consensus molecular subtype (CMS) classification for colorectal cancer any use in routine clinical practice?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19795991",
        "http://www.ncbi.nlm.nih.gov/pubmed/26364372",
        "http://www.ncbi.nlm.nih.gov/pubmed/24294121",
        "http://www.ncbi.nlm.nih.gov/pubmed/32215122",
        "http://www.ncbi.nlm.nih.gov/pubmed/32242614",
        "http://www.ncbi.nlm.nih.gov/pubmed/25587656",
        "http://www.ncbi.nlm.nih.gov/pubmed/19190304",
        "http://www.ncbi.nlm.nih.gov/pubmed/30507659",
        "http://www.ncbi.nlm.nih.gov/pubmed/20454824",
        "http://www.ncbi.nlm.nih.gov/pubmed/38726585"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19795991",
          "text": "Unusual manifestations of Clostridium difficile infection.. BACKGROUND: Clostridium difficile infection (CDI) is an increasing nosocomial problem. New, more-virulent strains of C. difficile have spread across North America and Europe. Health care ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6785266399383545,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26364372",
          "text": "[Clostridium difficile infection - an update].. Clostridium difficile infection represents a severe illness which very often results in emergency surgery, intensive care unit stay or death. Although standard treatment procedures are well known and...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6490665674209595,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24294121",
          "text": "Surgical Management of Clostridium difficile Colitis.. Clostridium difficile infection (CDI) will progress to fulminant disease in 3 to 5% of cases. With the emergence of hypervirulent, multidrug-resistant strains, the incidence and severity of di...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6395095586776733,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32215122",
          "text": "Guidelines for Clostridium difficile infection in adults.. Clostridium difficile infection (CDI) has become a serious medical and epidemiological problem, especially in well developed countries. There has been evident increase in incidence and sev...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6365465521812439,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32242614",
          "text": "Clostridium Difficile Infection Complicating Acute Severe Colitis During Pregnancy.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 83,
          "rerank_score": 0.6344916820526123,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25587656",
          "text": "Treatment of recurrent and severe Clostridium difficile infection.. Clostridium difficile infection (CDI) is a serious complication of hospitalization and antibiotic use with a high mortality and very high costs. Despite appropriate treatment, a s...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6323217749595642,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19190304",
          "text": "A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection.. Clostridium difficile infection (CDI) is a common and increasingly severe nosocomial infectious disease. The case of Mr S, a 76-year-old...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6283033490180969,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30507659",
          "text": "Pharmacologic Approach to Management of Clostridium difficile Infection.. Clostridium difficile is a gram-positive, anaerobic, spore-forming bacterium that is the leading cause of nosocomial infections in hospitals in the United States. Critically...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.624207615852356,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20454824",
          "text": "Review of medical and surgical management of Clostridium difficile infection.. Clostridium difficile infection (CDI) has become an important area in our daily clinical practice. C. difficile is known to cause a broad spectrum of conditions ranging...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.623924732208252,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/38726585",
          "text": "Clostridioides Difficile: A Concise Review of Best Practices and Updates.. Clostridioides difficile infection (CDI) is one of the most common and severe nosocomial infections worldwide. It can also affect healthy individuals in the community. The ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6216707229614258,
          "rerank_position": 10
        }
      ],
      "id": "67cddce881b102733300001c",
      "type": "list",
      "body": "Please list major complications of Clostridum Difficile infection."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/10352925",
        "http://www.ncbi.nlm.nih.gov/pubmed/17081931",
        "http://www.ncbi.nlm.nih.gov/pubmed/17304034",
        "http://www.ncbi.nlm.nih.gov/pubmed/26819214",
        "http://www.ncbi.nlm.nih.gov/pubmed/18087838",
        "http://www.ncbi.nlm.nih.gov/pubmed/26137726",
        "http://www.ncbi.nlm.nih.gov/pubmed/8567849",
        "http://www.ncbi.nlm.nih.gov/pubmed/30100006",
        "http://www.ncbi.nlm.nih.gov/pubmed/11033690",
        "http://www.ncbi.nlm.nih.gov/pubmed/26486483"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10352925",
          "text": "Diagnosis of polycystic ovary syndrome.. The clinical features of polycystic ovary syndrome (PCOS) include hirsutism and irregular menses, which are the results of ovarian hyperandrogenism and chronic, unopposed estrogen secretion. The discovery t...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8490593433380127,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17081931",
          "text": "Polycystic ovary syndrome.. Polycystic ovary syndrome (PCOS) is a common endocrine disorder, affecting between 4% and 8% of reproductive aged women. This syndrome, a complex disorder with multiple components, including reproductive, metabolic, and...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8419597148895264,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17304034",
          "text": "Diagnosis of polycystic ovary syndrome.. Polycystic ovary syndrome (PCOS) is a diagnosis of exclusion, with other androgen excess and ovulatory dysfunction disorders to be ruled out. There are 3 principal features of the syndrome, including hypera...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8379775285720825,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26819214",
          "text": "[Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS)].. Polycystic ovarian syndrome represents the most common endocrine disease of women of reproductive age. Symptoms include metabolic, gynecologic and cosmetic feature...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.833497166633606,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18087838",
          "text": "[Long-term health consequences of polycystic ovaries syndrome: metabolic, cardiovascular and oncological aspects].. The polycystic ovary syndrome (PCOS), then called the Stein-Leventhal syndrome, was first described in 1935. Originally, diagnosis ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8299176096916199,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26137726",
          "text": "Polycystic Ovarian Syndrome: A Primer.. Polycystic ovary syndrome (PCOS) affects 8-10 percent of reproductive-aged females, making it the most common state of endocrine dysfunction in women. Patients with PCOS are often treated for the signs and s...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8291078805923462,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8567849",
          "text": "Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients.. The criteria for the diagnosis of the polycystic ovary syndrome (PCOS) have still not been agreed universally. A population of 1741 women with PCOS were studied, all of who...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8290232419967651,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30100006",
          "text": "Polycystic Ovary Syndrome.. Polycystic ovary syndrome (PCOS) is a commonly occurring endocrine disorder characterized by hirsutism, anovulation, and polycystic ovaries. Often comorbid with insulin resistance, dyslipidemia, and obesity, it also car...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8284083008766174,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11033690",
          "text": "Polycystic ovary syndrome.. Polycystic ovary syndrome is a complex endocrine disorder of hypothalamic-pituitary dysfunction that presents with anovulation, hirsutism and infertility. Women with PCOS have increased risk for developing NIDDM, dyslip...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8255170583724976,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26486483",
          "text": "[Polycystic ovary syndrome].. For diagnosing of polycystic ovary syndrome (PCOS) it is currently recommended to follow the ESHRE criteria. For diagnosis according to them two of the following three symptoms are sufficient: 1. morphology of polycys...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8223781585693359,
          "rerank_position": 10
        }
      ],
      "id": "67d43cd218b1e36f2e000011",
      "type": "list",
      "body": "Symptoms of polycystic ovarian syndrome."
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/12509802",
        "http://www.ncbi.nlm.nih.gov/pubmed/22781495",
        "http://www.ncbi.nlm.nih.gov/pubmed/34153742",
        "http://www.ncbi.nlm.nih.gov/pubmed/23584611",
        "http://www.ncbi.nlm.nih.gov/pubmed/26709894",
        "http://www.ncbi.nlm.nih.gov/pubmed/30770136",
        "http://www.ncbi.nlm.nih.gov/pubmed/25200136",
        "http://www.ncbi.nlm.nih.gov/pubmed/21372517",
        "http://www.ncbi.nlm.nih.gov/pubmed/33994951",
        "http://www.ncbi.nlm.nih.gov/pubmed/29081882"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12509802",
          "text": "Early oligodendrocyte progenitor cells in the human fetal telencephalon.. Oligodendrocytes, the myelin-producing cells in the central nervous system, represent a large portion of the total number of cells in the human brain. Using cell-specific ma...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7278701066970825,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22781495",
          "text": "Oligodendrocyte progenitor cells derived from mouse embryonic stem cells give rise to type-1 and type-2 astrocytes in vitro.. Oligodendrocyte progenitor cells (OPCs) in primary culture can give rise to mature oligodendrocytes and type-2, but not t...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.715288519859314,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34153742",
          "text": "Oligodendrocyte progenitor cell fate and function in development and disease.. Differentiation of oligodendrocyte progenitor cells (OPCs) into myelination-capable mature oligodendrocytes is essential for proper function of the central nervous syst...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7102333307266235,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23584611",
          "text": "Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells.. Cell-based therapies for myelin disorders, such as multiple sclerosis and leukodystrophies, require technologies to generate ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7067036628723145,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26709894",
          "text": "Oligodendrocyte progenitor cells: the ever mitotic cells of the CNS.. Oligodendrocyte Progenitor Cells (OPCs) first appear at mid embryogenic stages during development of the mammalian CNS and a mitotically active population of them remains presen...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6958349943161011,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30770136",
          "text": "Molecular Control of Oligodendrocyte Development.. Myelin is a multilayer lipid membrane structure that wraps and insulates axons, allowing for the efficient propagation of action potentials. During developmental myelination of the central nervous...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6899049282073975,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25200136",
          "text": "Olig2 overexpression accelerates the differentiation of mouse embryonic stem cells into oligodendrocyte progenitor cells in vitro.. Oligodendrocyte progenitor cells (OPCs) transplantation is receiving considerable attention in the field of regener...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6836966276168823,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21372517",
          "text": "Differential gene expression in oligodendrocyte progenitor cells, oligodendrocytes and type II astrocytes.. Oligodendrocyte precursor cells (OPCs) are bipotential progenitor cells that can differentiate into myelin-forming oligodendrocytes or func...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6836134195327759,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33994951",
          "text": "Novel Tools and Investigative Approaches for the Study of Oligodendrocyte Precursor Cells (NG2-Glia) in CNS Development and Disease.. Oligodendrocyte progenitor cells (OPCs), also referred to as NG2-glia, are the most proliferative cell type in th...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6835366487503052,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29081882",
          "text": "Derivation of telencephalic oligodendrocyte progenitors from human pluripotent stem cells.. Oligodendrocytes are the main myelinating cell of the adult CNS and are vulnerable to injury in diverse disorders such as spinal cord injury, stroke, traum...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6703207492828369,
          "rerank_position": 10
        }
      ],
      "id": "67d9f6a418b1e36f2e000051",
      "type": "list",
      "body": "What are the lineage transcription factors of oligodendrocyte progenitor cells (OPCs)?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/39103897",
        "http://www.ncbi.nlm.nih.gov/pubmed/34766461",
        "http://www.ncbi.nlm.nih.gov/pubmed/34641707",
        "http://www.ncbi.nlm.nih.gov/pubmed/24293473",
        "http://www.ncbi.nlm.nih.gov/pubmed/15640936",
        "http://www.ncbi.nlm.nih.gov/pubmed/28408617",
        "http://www.ncbi.nlm.nih.gov/pubmed/18020912",
        "http://www.ncbi.nlm.nih.gov/pubmed/21885151",
        "http://www.ncbi.nlm.nih.gov/pubmed/17268335",
        "http://www.ncbi.nlm.nih.gov/pubmed/15287270"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39103897",
          "text": "Integrating knowledge graphs into machine learning models for survival prediction and biomarker discovery in patients with non-small-cell lung cancer.. Accurate survival prediction for Non-Small Cell Lung Cancer (NSCLC) patients remains a signific...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.62274169921875,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34766461",
          "text": "The need for speed in advanced non-small cell lung cancer: A population kinetics assessment.. BACKGROUND: Systemic therapy prolongs overall survival (OS) in advanced non-small cell lung cancer (NSCLC), but diagnostic tests, staging and molecular p...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.48131459951400757,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34641707",
          "text": "Keeping it real: implications of real-world treatment outcomes for first-line immunotherapy in metastatic non-small-cell lung cancer.. Tweetable abstract Recent RWD studies suggest that the performance of immunotherapy in NSCLC is not as good as t...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.46595022082328796,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24293473",
          "text": "Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy.. The aim of this article is to summarise the published data on prognostic and predictive biomarkers for early-stage non-small cell ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4637758135795593,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15640936",
          "text": "Meta-analyses of clinical trials in patients with non-small cell lung cancer. Minireview.. Currently lung cancer is the most common worldwide cause of major cancer incidence and mortality. The treatment outcome is poor and there are still many que...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4484920799732208,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28408617",
          "text": "Treatment Paradigms for Advanced Non-Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design.. UNLABELLED: Based on the positive results of various clinical trials, treatment options for non-small cell lun...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.43372052907943726,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18020912",
          "text": "Genomic signatures individualize therapeutic decisions in non-small-cell lung cancer.. Gene expression signatures have been developed in an effort to dissect the biologic phenotypes of malignancies. These signatures have tremendous power to identi...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.42618080973625183,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21885151",
          "text": "Predictive markers in the adjuvant therapy of non-small cell lung cancer.. Adjuvant chemotherapy increases the 5-year survival rate of patients with completely resected non-small cell lung cancer (NSCLC) by absolute 5%. Molecular-targeted therapie...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.41914981603622437,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17268335",
          "text": "[Early stages of non small cell lung cancer (I. II. IIIA). Role of preoperative treatments].. The first meta-analysis of preoperative chemotherapy in non-small cell lung cancer (NSCLC) was published by Berghmans et coll. It included the first six ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4191121459007263,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15287270",
          "text": "Outcomes research in cancer clinical trial cooperative groups: the RTOG model.. BACKGROUND: The Radiation Therapy Oncology Group (RTOG), a National Cancer Institute sponsored cancer clinical trials research cooperative, has recently formed an Outc...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.41850268840789795,
          "rerank_position": 10
        }
      ],
      "id": "67d7531018b1e36f2e000041",
      "type": "list",
      "body": "Data from which clinical trials have been used to demonstrate use of knowledge graphs for NSCLC survival prediction?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/8607012",
        "http://www.ncbi.nlm.nih.gov/pubmed/8829326",
        "http://www.ncbi.nlm.nih.gov/pubmed/25469031",
        "http://www.ncbi.nlm.nih.gov/pubmed/8813770",
        "http://www.ncbi.nlm.nih.gov/pubmed/34798980",
        "http://www.ncbi.nlm.nih.gov/pubmed/10756821",
        "http://www.ncbi.nlm.nih.gov/pubmed/16323029",
        "http://www.ncbi.nlm.nih.gov/pubmed/30192330",
        "http://www.ncbi.nlm.nih.gov/pubmed/17147127",
        "http://www.ncbi.nlm.nih.gov/pubmed/15666113"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8607012",
          "text": "Surgical options for familial adenomatous polyposis.. Familial adenomatous polyposis (FAP) is a genetic disorder transmitted in an autosomal dominant pattern. One-half of members of an affected family will carry the gene, and all carriers will suc...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7481940984725952,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8829326",
          "text": "Operations for familial adenomatous polyposis.. The purpose of this article is to discuss the advantages and disadvantages of surgical procedures designed to eliminate the risk of colorectal cancer, the surgical treatment of extracolonic polyps, a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7221981883049011,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25469031",
          "text": "Surgical treatment of familial adenomatous polyposis: dilemmas and current recommendations.. Familial adenomatous polyposis (FAP) is an autosomal dominant inherited syndrome characterized by multiple adenomatous polyps (predisposing to colorectal ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7214018106460571,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8813770",
          "text": "Choice of prophylactic surgery for the large bowel component of familial adenomatous polyposis.. The surgical options for treating the large bowel component of familial adenomatous polyposis are total proctocolectomy, colectomy with ileorectal ana...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7109370827674866,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34798980",
          "text": "Endoscopic Management and Surgical Considerations for Familial Adenomatous Polyposis.. Familial adenomatous polyposis (FAP) is the development of many adenomatous colorectal polyps. Colonoscopy is recommended to start at age 10 to 12 years at inte...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7058579921722412,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10756821",
          "text": "Familial adenomatous polyposis--which operation?. Familial adenomatous polyposis (FAP) syndromes are well recognized entities that benefit from surgical treatment which should not be delayed. Screening of first degree relatives is important. The a...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6963967084884644,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16323029",
          "text": "[Preventive surgery for familial adenomatous polyposis coli].. Familial adenomatous polyposis coli (FAP) may not be considered a single disease entity with standardized guidelines for operative treatment. However, prophylactic colectomy after the ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6953964233398438,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30192330",
          "text": "Life After Surgery: Surgeon Assessments of Quality of Life Among Patients With Familial Adenomatous Polyposis.. BACKGROUND: Without prophylactic surgery, patients with familial adenomatous polyposis are at high risk for colorectal cancer developme...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6940596699714661,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17147127",
          "text": "[Surgical treatment for familial adenomatous polyposis].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 56,
          "rerank_score": 0.6911677122116089,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15666113",
          "text": "Familial adenomatous polyposis. Surgical treatment: when and how.. Familial adenomatous polyposis is an autosomal dominated inherited disease, caused by the mutation of the tumour suppressor gene adenomatous polyposis coli on chromosome 5. Despite...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6909118890762329,
          "rerank_position": 10
        }
      ],
      "id": "660999a0fdcbea915f00001a",
      "type": "list",
      "body": "What are the colorectal surgical options for patients with Familial Polyposis?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/39273517",
        "http://www.ncbi.nlm.nih.gov/pubmed/31936524",
        "http://www.ncbi.nlm.nih.gov/pubmed/35628659",
        "http://www.ncbi.nlm.nih.gov/pubmed/36232726",
        "http://www.ncbi.nlm.nih.gov/pubmed/37628632",
        "http://www.ncbi.nlm.nih.gov/pubmed/35327996",
        "http://www.ncbi.nlm.nih.gov/pubmed/34013567"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39273517",
          "text": "Mucopolysaccharidosis-Plus Syndrome: Is This a Type of Mucopolysaccharidosis or a Separate Kind of Metabolic Disease?. Several years ago, dozens of cases were described in patients with symptoms very similar to mucopolysaccharidosis (MPS). This ne...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8091616630554199,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31936524",
          "text": "Mucopolysaccharidosis-Plus Syndrome.. Previously, we reported a novel disease of impaired glycosaminoglycans (GAGs) metabolism without deficiency of known lysosomal enzymes-mucopolysaccharidosis-plus syndrome (MPSPS). MPSPS, whose pathophysiology ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7941837310791016,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35628659",
          "text": "Hematopoietic Disorders, Renal Impairment and Growth in Mucopolysaccharidosis-Plus Syndrome.. Mucopolysaccharidoses (MPS) are rare lysosomal storage disorders (LSD) characterized by the excessive accumulation of glycosaminoglycans (GAG). Conventio...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7359828352928162,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36232726",
          "text": "Mucopolysaccharidosis-Plus Syndrome: Report on a Polish Patient with a Novel VPS33A Variant with Comparison with Other Described Patients.. Eleven patients from Yakutia with a new lysosomal disease assumed then as mucopolysaccharidosis-plus syndro...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6746306419372559,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/37628632",
          "text": "Prenatal Diagnosis of Mucopolysaccharidosis-Plus Syndrome (MPSPS).. Mucopolysaccharidosis-plus syndrome (MPSPS) is an autosomal-recessive disorder caused by c.1492C>T (p.R498W) in the VPS33A gene. MPSPS is a severe disorder that causes a short lif...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.6057068109512329,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35327996",
          "text": "Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child.. Mucopolysaccharidosis-plus syndrome (MPS-PS) is a novel autosomal recessive disorder cau...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5878419876098633,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34013567",
          "text": "Homozygous missense VPS16 variant is associated with a novel disease, resembling mucopolysaccharidosis-plus syndrome in two siblings.. Disorders of intracellular trafficking are a group of inherited disorders, which often display multisystem pheno...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.5251376628875732,
          "rerank_position": 7
        }
      ],
      "id": "67c7708481b1027333000002",
      "type": "yesno",
      "body": "Is mucopolysaccharidosis-plus syndrome (MPSPS) a X-linked disease?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/5856557",
        "http://www.ncbi.nlm.nih.gov/pubmed/2408143",
        "http://www.ncbi.nlm.nih.gov/pubmed/18900564",
        "http://www.ncbi.nlm.nih.gov/pubmed/2138",
        "http://www.ncbi.nlm.nih.gov/pubmed/23009963",
        "http://www.ncbi.nlm.nih.gov/pubmed/964850",
        "http://www.ncbi.nlm.nih.gov/pubmed/25095604",
        "http://www.ncbi.nlm.nih.gov/pubmed/19110959",
        "http://www.ncbi.nlm.nih.gov/pubmed/8121599",
        "http://www.ncbi.nlm.nih.gov/pubmed/29560505"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/5856557",
          "text": "[Indications for vaginal cesarean].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 35,
          "rerank_score": 0.8876097202301025,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2408143",
          "text": "[Indications for cesarean section].. Following introductory remarks on rates of cesarean section, the relative and absolute indications for the procedure are reviewed. The rise in the rate of cesarean sections is due to widening of the relative in...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.8396786451339722,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18900564",
          "text": "[Indication for Caesarean section delivery].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 44,
          "rerank_score": 0.8283350467681885,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2138",
          "text": "[Indications for cesarean section: indication and status of the newborn infant after surgery].",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 94,
          "rerank_score": 0.7968995571136475,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23009963",
          "text": "When is primary cesarean appropriate: maternal and obstetrical indications.. To describe appropriate maternal and obstetrical indications for primary cesarean delivery. The list of potential indications is long. Among all maternal and obstetrical ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7961553931236267,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/964850",
          "text": "[Indications for vital and preventive cesarean section].. The indications for Caesarean section have not only increased but also changed. A spectrum of indications is described which comprises emergency and preventive indications. The postpartal s...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7633949518203735,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25095604",
          "text": "[What should we tell our patient who requires cesarean section?].. Cesarean section on maternal request is defined as a primary prelabor cesarean delivery on maternal request with no maternal or fetal indications. There are many controversies surr...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7483668923377991,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19110959",
          "text": "[Caesarean section--indication or choice?].. Currently, caesarean section is the most commonly indicated procedure. The proportion of caesarean deliveries continues to rise. And the spectrum of surgical indications has dramatically broadened. This...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7418526411056519,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8121599",
          "text": "[Evaluation of indications for cesarean section. Comparison of two decades. Preliminary results].. We have retrospectively analysed the incidence of cesarean section during the periods 1970-79 and 1981-90 and the evolution, if any, of the principa...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7377479076385498,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29560505",
          "text": "Non-obstetrical indications for cesarean section: a state-of-the-art review.. PURPOSE: To propose an evidence-based review on the most frequent indications for Cesarean section (CS) given by specialists in disciplines other than Obstetrics and Gyn...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.7277891635894775,
          "rerank_position": 10
        }
      ],
      "id": "67d7201b18b1e36f2e00002c",
      "type": "list",
      "body": "Indications of cesarean section."
    }
  ]
}